State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Oura smart rings will soon be able to help users track their blood sugar levels through a new partnership with Dexcom (DXCM), ...

Drugmakers are likewise reaching out to other employers with the message that treating obesity will ultimately save them money.

With nearly $14 billion sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

Novo Nordisk continues to witness strong growth across its portfolio of diabetes and obesity care medications. The company's tailwinds include expanded indications and new geographic markets.

Novo Nordisk (NVO) has released an update. Don't Miss our Black Friday Offers: Novo Nordisk has launched a share repurchase program, aiming to buy back B shares worth up to DKK 20 billion over a ...